Travel Vaccines Market Research Report

Travel Vaccines Market Size:

Consegic Business Intelligence analyses that the travel vaccines market size is growing with a healthy CAGR of 10.2% during the forecast period (2023-2030), and the market is projected to be valued at USD 7,137.89 million by 2030 from USD 3,290.00 million in 2022.

Market Overview

The travel vaccines market encompasses a range of vaccines administered to individuals traveling to regions with endemic diseases. These vaccines protect travellers from infectious diseases such as hepatitis A and B, typhoid, yellow fever, Japanese encephalitis, and rabies. The market is driven by factors such as increasing global travel and tourism, rising awareness of travel-related health risks, and advancements in vaccine technology.

Key Factors Contributing to Market Growth

• Increasing Global Travel and Tourism: The surge in global travel and tourism, driven by factors such as globalization, economic growth, and increased disposable incomes, is a major driver of the travel vaccines market.
• Rising Awareness of Travel-Related Health Risks: Growing awareness among travellers about the risks of infectious diseases prevalent in different regions is driving demand for travel vaccines.
• Advancements in Vaccine Technology: Continuous advancements in vaccine technology, such as the development of combination vaccines and improved delivery methods, are enhancing the effectiveness and convenience of travel vaccinations.
• Government Regulations and Travel Advisories: Government travel advisories and mandatory vaccination requirements for certain destinations are driving demand for travel vaccines.

Travel Vaccines Market Dynamics (DRO): Drivers, Restraints and Opportunities

• Drivers:
  • Increasing global travel and tourism
  • Rising awareness of travel-related health risks
  • Advancements in vaccine technology
  • Government travel advisories and mandatory vaccination requirements
• Restraints:
  • High cost of travel vaccines
  • Limited access to travel clinics and vaccination services in some regions
  • Vaccine hesitancy and concerns about vaccine safety
  • Potential for adverse reactions to vaccines
• Opportunities:
  • Developing travel-specific vaccine combinations to improve convenience and reduce the number of injections required
  • Expanding access to travel vaccination services in underserved communities
  • Collaborating with travel agencies and tour operators to promote travel vaccinations
  • Developing innovative delivery methods, such as needle-free injections, to improve patient comfort

Travel Vaccines Market Key Players

• GSK plc.
• Sanofi
• Valneva SE
• Abbott
• AstraZeneca